Showing results (2061-2070 of 3,418) with videos related to

Sort By:
Pageof 342
Eclinicalmedicine|September 19, 2022
The effectiveness of lifestyle interventions on type 2 diabetes and gestational diabetes incidence and cardiometabolic outcomes: A systematic review and meta-analysis of evidence from low- and middle-income countriesDiana Sagastume, Irene Siero, Elly Mertens, et al.
Eclinicalmedicine|October 24, 2022
Early recognition and response to increases in surgical site infections using optimised statistical process control charts-The early 2RIS trial: A multicentre stepped wedge cluster randomised controlled trialArthur W Baker, Iulian Ilieş, James C Benneyan, et al.
Eclinicalmedicine|November 29, 2023
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)Wensi Zhao, Jun Lei, Shaobo Ke, et al.
Eclinicalmedicine|December 4, 2023
Clinician preferences on treatment of smoldering myeloma: a cross-sectional surveyGhulam Rehman Mohyuddin, Rajshekhar Chakraborty, Edward R Scheffer Cliff, et al.
Eclinicalmedicine|November 29, 2023
Safety and effectiveness of COVID-19 vaccines in patients with IgA nephropathy: a retrospective cohort study from the TriNetX global collaborative networksCheng-Hsu Chen, Ming-Ju Wu, Shang-Feng Tsai
Eclinicalmedicine|November 29, 2023
When the cause of death does not exist: time for the WHO to close the ICD classification gap for Medical Aid in DyingUwe Güth, Rolf Weitkunat, Shaun McMillan, et al.
Eclinicalmedicine|November 15, 2023
Effects of gender and socio-environmental factors on health-care access in oncology: a comprehensive, nationwide study in FranceFloriane Jochum, Anne-Sophie Hamy, Paul Gougis, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
Eclinicalmedicine|January 18, 2024
Impact of vaccination and high-risk group awareness on the mpox epidemic in the United States, 2022-2023: a modelling studyYin-Chien Lin, Tzai-Hung Wen, Wei-Liang Shih, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Pageof 342